Spinocerebellar ataxia type 35 (SCA35) is a rare, inherited neurological disorder that affects the cerebellum, a part of the brain that controls movement and coordination. It is characterized by progressive difficulty with coordination, balance, and speech. Symptoms typically begin in adulthood and worsen over time. Other symptoms may include difficulty swallowing, muscle weakness, and vision problems. There is currently no cure for SCA35, but treatments are available to help manage symptoms.

The symptoms of Spinocerebellar Ataxia type 35 (SCA35) vary from person to person, but may include:

• Unsteady gait

• Impaired coordination

• Difficulty with fine motor skills

• Slurred speech

• Muscle weakness

• Tremors

• Loss of balance

• Difficulty with eye movements

• Cognitive impairment

• Loss of bladder and/or bowel control

• Fatigue

• Depression

• Anxiety

Spinocerebellar ataxia type 35 (SCA35) is a rare, inherited neurological disorder caused by a mutation in the SETX gene. This gene is responsible for producing a protein called senataxin, which is involved in the maintenance of the nervous system. Mutations in the SETX gene lead to a decrease in the amount of senataxin produced, which in turn causes the symptoms of SCA35.

1. Physical therapy: Physical therapy can help improve balance, coordination, and strength. It can also help with activities of daily living, such as walking, dressing, and eating.

2. Occupational therapy: Occupational therapy can help with activities of daily living, such as dressing, eating, and writing.

3. Speech therapy: Speech therapy can help with communication and swallowing difficulties.

4. Medications: Medications can help reduce symptoms, such as tremor, muscle spasms, and difficulty walking.

5. Surgery: Surgery may be recommended in some cases to help improve balance and coordination.

6. Assistive devices: Assistive devices, such as canes, walkers, and wheelchairs, can help with mobility.

7. Nutritional counseling: Nutritional counseling can help ensure that you are

1. Age: Spinocerebellar ataxia type 35 (SCA35) is a rare, autosomal dominant disorder that typically presents in adulthood.

2. Genetics: SCA35 is caused by a mutation in the ATXN7 gene.

3. Family history: Individuals with a family history of SCA35 are at an increased risk of developing the disorder.

4. Gender: SCA35 is more common in males than females.

At this time, there is no cure for Spinocerebellar ataxia type 35 (SCA35). However, there are medications that can help manage the symptoms of SCA35. These medications include anticonvulsants, muscle relaxants, and medications to help with balance and coordination. Additionally, physical and occupational therapy can help improve balance and coordination.